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Background
Clinical practice guidelines are an increasingly
common element of clinical care throughout the
world. Such guidelines have the potential to
improve the care received by patients by
promoting interventions of proven benefit and
discouraging ineffective interventions. However,
the development and introduction of guidelines
are not without costs. In some circumstances, the
costs of development and introduction are likely to
outweigh their potential benefits. In other
circumstances, it may be more efficient to adopt
less costly but less effective dissemination and
implementation strategies. Local healthcare
organisations have relatively few resources for
clinical effectiveness activities and policy makers
need to consider how best to use these to
maximise benefits. 
Objectives
The aims of the study were:
 to undertake a systematic review of the
effectiveness and costs of different guideline
development, dissemination and
implementation strategies
 to estimate the resource implications of
different development, dissemination and
implementation strategies
 to develop a framework for deciding when it is
efficient to develop and introduce clinical
guidelines based upon the potential costs and
benefits of the targeted clinical activity and the
effectiveness and costs of guideline
development and introduction.
Methods
Systematic review of the effectiveness
and efficiency of guideline
dissemination and implementation
strategies
Data sources 
MEDLINE (1966–1998), Healthstar (1975–1998),
Cochrane Controlled Trial Register (4th edition
1998), EMBASE (1980–1998), SIGLE (1980–1988)
and the specialised register of the Cochrane
Effective Practice and Organisation of Care
(EPOC) group were searched using a gold
standard search strategy developed from
handsearches of key journals. The search strategy
was 93% sensitive and 18% specific.
Study selection (inclusion criteria)
 Types of study design: randomised controlled
trials, controlled clinical trials, controlled before
and after studies and interrupted time series
 types of participant: medically qualified healthcare
professionals
 types of intervention: guideline dissemination and
implementation strategies
 types of outcome: objective measures of provider
behaviour and/or patient outcome.
Data extraction (and assessment of validity)
Two reviewers independently abstracted data on
the methodological quality of the studies (using
the Cochrane EPOC group’s methodological
quality criteria), characteristics of study setting,
participants, targeted behaviours and
characteristics of interventions. Studies reporting
economic evaluations and cost analyses were
further assessed against the British Medical 
Journal guidelines for reviewers of economic
evaluations. 
Data synthesis
Single estimates of dichotomous process variables
(e.g. proportion of patients receiving appropriate
treatment) were derived for each study
comparison based upon the primary end-point (as
defined by the authors of the study) or the median
measure across several reported end-points. An
attempt was made to reanalyse studies with
common methodological weaknesses. Separate
analyses were undertaken for comparisons of
single interventions against ‘no-intervention’
controls, single interventions against controls
receiving interventions, multifaceted interventions
against ‘no-intervention’ controls and multifaceted
interventions against controls receiving
interventions. The study also explored whether
the effects of multifaceted interventions increased
with the number of intervention components. For
each intervention, the number of comparisons
showing a positive direction of effect, the 
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median effect size across all comparisons, the
median effect size across comparisons without unit
of analysis errors, and the number of comparisons
showing statistically significant effects were
reported. A planned meta-regression analysis
could not be undertaken owing to the large
number of different combinations of multifaceted
interventions.
Survey of estimating the feasibility 
and likely resource requirements of
guideline dissemination and
implementation strategies in 
UK settings 
Telephone interviews were conducted with key
informants from primary and secondary care.
Results (research findings)
Systematic review of the effectiveness
and efficiency of guideline
dissemination and implementation
strategies
In total, 235 studies reporting 309 comparisons
met the inclusion criteria. The overall quality of
the studies was poor. Seventy-three per cent of
comparisons evaluated multifaceted interventions,
although the maximum number of replications of
a specific multifaceted intervention was 11
comparisons. Overall, the majority of comparisons
reporting dichotomous process data (86.6%)
observed improvements in care; however, there
was considerable variation in the observed effects
both within and across interventions. Commonly
evaluated single interventions were reminders (38
comparisons), dissemination of educational
materials (18 comparisons) and audit and
feedback (12 comparisons). There were 23
comparisons of multifaceted interventions
involving educational outreach. The majority of
interventions observed modest to moderate
improvements in care. For example, the median
absolute improvement in performance across
interventions was 14.1% in 14 cluster randomised
comparisons of reminders, 8.1% in four cluster
randomised comparisons of dissemination of
educational materials, 7.0% in five cluster
randomised comparisons of audit and feedback
and 6.0% in 13 cluster randomised comparisons of
multifaceted interventions involving educational
outreach. No relationship was found between the
number of component interventions and the
effects of multifaceted interventions.
Only 29.4% of comparisons reported any
economic data. Eleven reported cost-effectiveness
analyses, 38 reported cost consequence analyses
(where differences in cost were set against
differences in several measures of effectiveness)
and 14 reported cost analyses (where some aspect
of cost was reported but not related to benefits).
The majority of studies only reported costs of
treatment; only 25 studies reported data on the
costs of guideline development or guideline
dissemination and implementation. The majority
of studies used process measures for their primary
end-point, despite the fact that only three
guidelines were explicitly evidence based (and may
not have been efficient). Overall, the methods of
the economic evaluations and cost analyses were
poor. The viewpoint adopted in economic
evaluations was only stated in ten studies. The
methods to estimate costs were comprehensive in
about half of the studies, and few studies reported
details of resource use. Owing to the poor quality
of reporting of the economic evaluation, data on
resource use and cost of guideline development,
dissemination and implementation were not
available for most of the studies; only four studies
provided sufficiently robust data for abstraction. 
Survey of estimating the feasibility 
and likely resource requirements of
guideline dissemination and
implementation strategies in 
UK settings 
Respondents rarely identified existing budgets to
support guideline dissemination and
implementation strategies and made frequent
comments about using ‘soft money’ or resources
for specific initiatives to support such activities. In
general, the respondents thought that only
dissemination of educational materials and short
(lunchtime) educational meetings were generally
feasible within current resources. 
Conclusions: implications for
healthcare and recommendations
for research
There is an imperfect evidence base to support
decisions about which guideline dissemination and
implementation strategies are likely to be efficient
under different circumstances. Decision makers
need to use considerable judgement about how
best to use the limited resources they have for
clinical governance and related activities to
maximise population benefits. They need to
consider the potential clinical areas for clinical
effectiveness activities, the likely benefits and 
costs required to introduce guidelines and 
Health Technology Assessment 2004; Vol. 8: No. 6 (Executive summary)

the likely benefits and costs as a result of any
changes in provider behaviour. Further research is
required to: develop and validate a coherent
theoretical framework of health professional and
organisational behaviour and behaviour change to
inform better the choice of interventions in
research and service settings, and to estimate the
efficiency of dissemination and implementation
strategies in the presence of different barriers and
effect modifiers. 
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